documents: FDA-2018-N-2727-0042

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2018-N-2727-0042 FDA FDA-2018-N-2727 Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations; Reopening of Comment Period Proposed Rule Extension of Comment Period 2019-02-25T05:00:00Z 2019 2 2019-02-25T05:00:00Z 2019-03-08T04:59:59Z 2019-03-09T02:02:09Z 2019-03195 0 0 0900006483aa313c

Links from other tables